Position in HLN
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$46,375
-$9,107 QoQ
Shares Held
4,633
-15.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CARY STREET PARTNERS INVESTMENT ADVISORY LLC holds $134,828 across 3 Drug Manufacturers - Specialty & Generic names.
All Filings in HLN
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $46,375 | 4,633 | Shares | Other | 2026-04-29 | |
| 2025-12-31 | $55,482 | 5,488 | Shares | Other | 2026-02-09 | |
| 2025-09-30 | $61,999 | 6,912 | Shares | Other | 2025-11-10 | |
| 2025-06-30 | $73,232 | 7,062 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $75,167 | 7,305 | Shares | Other | 2025-05-09 | |
| 2024-12-31 | $3,539 | 371 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $208,721 | 19,728 | Shares | Defined | 2024-10-30 | |
| 2024-06-30 | $250,475 | 30,324 | Shares | Other | 2024-07-22 | |
| 2024-03-31 | $125,898 | 14,829 | Shares | Defined | 2024-04-30 | |
| 2023-09-30 | $57,960 | 6,958 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $62,590 | 7,469 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $45,901 | 5,639 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $55,112 | 6,889 | Shares | Defined | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||